Retatrutide 16mg

Description

Retatrutide is an innovative, once‑weekly injectable designed to transform weight management and metabolic health by activating GIP, GLP‑1, and glucagon.

How It Works

• GLP‑1 Agonism: Reduces appetite and improves glycemic control.
• GIP Agonism: Enhances weight loss and glycemic benefits.
• Glucagon Agonism: Increases energy expenditure and reduces liver fat.
• Triple‑Action: Targets appetite, energy use, glucose metabolism, and liver fat.

Key Benefits

• Weight Loss: Up to 20% body weight reduction in high‑dose groups.
• Blood Sugar Control: Rapid, sustained improvements in A1C levels.
• Liver Fat Reduction: Significant decreases in NAFLD subgroups.
• Tolerability: Generally well‑tolerated with mild, transient side effects.

Usage

• Once or bi‑weekly subcutaneous injection with titration.
• Part of a comprehensive weight‑management program including diet and activity.